• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人CD38可溶性形式在大肠杆菌和毕赤酵母中的功能表达。

Functional expression of soluble forms of human CD38 in Escherichia coli and Pichia pastoris.

作者信息

Fryxell K B, O'Donoghue K, Graeff R M, Lee H C, Branton W D

机构信息

Department of Physiology, University of Minnesota, Minneapolis 55455, USA.

出版信息

Protein Expr Purif. 1995 Jun;6(3):329-36. doi: 10.1006/prep.1995.1043.

DOI:10.1006/prep.1995.1043
PMID:7663169
Abstract

Cyclic adenosine diphosphate (ADP)-ribose (cADPR), a metabolite of nicotinamide adenine dinucleotide (NAD+), mobilizes calcium from intracellular stores in many cells. The synthesis of cADPR from NAD+ and its subsequent hydrolysis to ADPR is catalyzed by an ADP-ribosyl cyclase and a cADPR hydrolase, respectively. The ADP-ribosyl cyclase cloned from the ovotestis of the marine invertebrate Aplysia californica has amino acid sequence homology to the human lymphocyte surface antigen CD38. CD38 has been shown to catalyze both the formation and the hydrolysis of cADPR. In this study, we produced soluble, enzymatically active CD38 using recombinant expression techniques in bacteria and yeast. We engineered a gene coding for a soluble form of CD38 by excision of the region of the gene coding for the N-terminal amino acids representing the putative membrane spanning sequence and short putative intracellular sequence. For expression in bacteria (Escherichia coli), this construct was cloned into the pFlag-1 plasmid which allows induced, periplasmic expression and relatively simple purification of the soluble CD38. For expression in yeast (Pichia pastoris) the CD38 sequence was further modified to eliminate four putative N-linked glycosylation sites and the resulting construct was expressed as a secreted protein. Both systems produce soluble enzymes of approximately 30 kDa and both recombinant enzymes display similar cyclase and hydrolase activities.

摘要

环磷酸腺苷二磷酸核糖(cADPR)是烟酰胺腺嘌呤二核苷酸(NAD+)的一种代谢产物,可在许多细胞中从细胞内储存库中动员钙。从NAD+合成cADPR及其随后水解为ADPR分别由ADP-核糖基环化酶和cADPR水解酶催化。从海洋无脊椎动物加州海兔的卵睾体中克隆的ADP-核糖基环化酶与人类淋巴细胞表面抗原CD38具有氨基酸序列同源性。已证明CD38可催化cADPR的形成和水解。在本研究中,我们利用细菌和酵母中的重组表达技术制备了可溶性、具有酶活性的CD38。我们通过切除编码代表推定跨膜序列和短推定细胞内序列的N端氨基酸区域的基因片段,构建了一个编码可溶性CD38形式的基因。为了在细菌(大肠杆菌)中表达,该构建体被克隆到pFlag-1质粒中,该质粒允许诱导性周质表达和相对简单地纯化可溶性CD38。为了在酵母(毕赤酵母)中表达,CD38序列被进一步修饰以消除四个推定的N-糖基化位点,所得构建体作为分泌蛋白表达。这两种系统都产生约30 kDa的可溶性酶,并且两种重组酶都表现出相似的环化酶和水解酶活性。

相似文献

1
Functional expression of soluble forms of human CD38 in Escherichia coli and Pichia pastoris.人CD38可溶性形式在大肠杆菌和毕赤酵母中的功能表达。
Protein Expr Purif. 1995 Jun;6(3):329-36. doi: 10.1006/prep.1995.1043.
2
Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38.淋巴细胞抗原CD38催化的环ADP核糖的形成与水解
Science. 1993 Nov 12;262(5136):1056-9. doi: 10.1126/science.8235624.
3
CD38 and ADP-ribosyl cyclase catalyze the synthesis of a dimeric ADP-ribose that potentiates the calcium-mobilizing activity of cyclic ADP-ribose.CD38和ADP-核糖基环化酶催化二聚体ADP-核糖的合成,该二聚体可增强环ADP-核糖的钙动员活性。
J Biol Chem. 1997 May 16;272(20):12945-51. doi: 10.1074/jbc.272.20.12945.
4
Lysine 129 of CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) participates in the binding of ATP to inhibit the cyclic ADP-ribose hydrolase.CD38(ADP核糖基环化酶/环ADP核糖水解酶)的赖氨酸129参与ATP的结合以抑制环ADP核糖水解酶。
J Biol Chem. 1997 Feb 14;272(7):3879-82. doi: 10.1074/jbc.272.7.3879.
5
ADP-ribosyl cyclase and CD38 catalyze the synthesis of a calcium-mobilizing metabolite from NADP.ADP-核糖基环化酶和CD38催化从NADP合成一种可动员钙的代谢产物。
J Biol Chem. 1995 Dec 22;270(51):30327-33. doi: 10.1074/jbc.270.51.30327.
6
Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP.人白细胞抗原CD38介导的环ADP核糖的合成与水解以及ATP对水解的抑制作用
J Biol Chem. 1993 Dec 15;268(35):26052-4.
7
Essential cysteine residues for cyclic ADP-ribose synthesis and hydrolysis by CD38.CD38合成和水解环二磷酸腺苷核糖所必需的半胱氨酸残基。
J Biol Chem. 1994 Nov 18;269(46):28555-7.
8
Regulatory role of CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in insulin secretion by glucose in pancreatic beta cells. Enhanced insulin secretion in CD38-expressing transgenic mice.CD38(ADP-核糖基环化酶/环ADP-核糖水解酶)在胰腺β细胞中对葡萄糖诱导的胰岛素分泌的调节作用。在表达CD38的转基因小鼠中胰岛素分泌增强。
J Biol Chem. 1995 Dec 15;270(50):30045-50. doi: 10.1074/jbc.270.50.30045.
9
Human gene encoding CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase): organization, nucleotide sequence and alternative splicing.编码CD38(ADP-核糖基环化酶/环ADP-核糖水解酶)的人类基因:结构、核苷酸序列及可变剪接
Gene. 1997 Feb 28;186(2):285-92. doi: 10.1016/s0378-1119(96)00723-8.
10
The transmembrane glycoprotein CD38 is a catalytically active transporter responsible for generation and influx of the second messenger cyclic ADP-ribose across membranes.跨膜糖蛋白CD38是一种具有催化活性的转运蛋白,负责第二信使环磷酸腺苷核糖在细胞膜上的生成和内流。
FASEB J. 1998 Nov;12(14):1507-20. doi: 10.1096/fasebj.12.14.1507.

引用本文的文献

1
Resolving the topological enigma in Ca signaling by cyclic ADP-ribose and NAADP.通过环 ADP-核糖和 NAADP 解决钙信号中的拓扑难题。
J Biol Chem. 2019 Dec 27;294(52):19831-19843. doi: 10.1074/jbc.REV119.009635. Epub 2019 Oct 31.
2
N-linked glycosylation of CD38 is required for its structure stabilization but not for membrane localization.CD38的N-糖基化对于其结构稳定是必需的,但对于膜定位并非必需。
Mol Cell Biochem. 2007 Jan;295(1-2):1-7. doi: 10.1007/s11010-006-9265-9. Epub 2006 Jul 14.
3
Recombinant protein expression in Pichia pastoris.
毕赤酵母中的重组蛋白表达。
Mol Biotechnol. 2000 Sep;16(1):23-52. doi: 10.1385/MB:16:1:23.
4
Structures and activities of cyclic ADP-ribose, NAADP and their metabolic enzymes.环磷酸腺苷核糖、烟酰胺腺嘌呤二核苷酸磷酸及其代谢酶的结构与活性
Mol Cell Biochem. 1999 Mar;193(1-2):89-98. doi: 10.1007/978-1-4419-8740-2_13.
5
Novel peptide inhibitor of ecto-ADP-ribosyl cyclase of bone marrow stromal cell antigen-1 (BST-1/CD157).骨髓基质细胞抗原-1(BST-1/CD157)胞外ADP-核糖基环化酶的新型肽抑制剂
Biochem J. 1999 Feb 1;337 ( Pt 3)(Pt 3):491-6.